France – Pharmaceutical products – Système d'acquisition dynamique pour la fourniture de produits pharmaceutiques : médicaments et solutés versables
Opportunity Score
Confidence: 50%
Complexity: medium
2846 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This is a Dynamic Acquisition System (DPS) for the supply of pharmaceutical products (medicines and infusible solutions) published by GCS Achats du Centre in France. It includes 8 lots covering various therapeutic categories. The DPS runs from 2025 to 2034, with a very long duration (109 months). No estimated value is provided. The procedure is restricted, and submission is electronic only in French. Selection criteria require DC1 and DC2 forms; award criteria are not specified. The DPS allows continuous entry of candidates until the end of the system.
Strengths
Documents available
Medium complexity
2846 days left
Risks
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Electronic submission is mandatory.
- Tenders must be submitted in French.
- Restricted procedure: candidates must express interest and be selected to participate.
Buyer
Name
GCS Achats du Centre
Location
Blois, FRA
Website
Buyer profile
Identifier
65455
Lots (8)
Competition within a therapeutic class
Injectable anticancer drugs
Injectable generics and other routes, except dry oral forms
Procurement Details
Publication
03 Feb 2025
Deadline
31 Mar 2034, 21:59
Procedure
restricted
Contract
supplies
Duration
109 MONTH
Language
FRA
Publication #
75383-2025
Classification
Documents (2)
Opportunity Score
Confidence: 50%
Complexity: medium
2846 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation